NFKB1 and chronic kidney disease: Our findings demonstrate that SSKE improves the physical structure and pathological morphology of the intestine and kidney, attenuates the inflammatory response, and reduces the secretion of TNF-α and IL-6 cytokines in CKD through the NF-κB pathway.